In T2DM individuals, circulating GLP-1 levels are similar to those found in normoglycemic individuals, yet partial resistance to the insulinotropic effects of GLP-1RA is seen in some T2DM patients at physiological and pharmacological concentrations. This evidence concerns the gene GCG and type 2 diabetes mellitus.